Brain Oxygenation During Prehospital Anesthesia
- Conditions
- Critical Illness
- Registration Number
- NCT03948711
- Lead Sponsor
- Helsinki University Central Hospital
- Brief Summary
The study will evaluate the feasibility of Nonin SenSmart H500 device to measuring brain oxygenation during prehospital anesthesia of adult patient. The study also estimates the incidence of cerebral hypoxic events of anesthetized patients during prehospital care. The study does not affect the treatment of the patient. The study is pilot study and will be followed with a main study to assess the association between cerebral oxygenation during prehospital care and outcome of the patient.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- sedation or anesthesia provided to facilitate endotracheal intubation, performed by HEMS team regardless of the reason
- Cardiac arrest at the time of intubation
- Physical barrier for NIRS measuring (e.g. forehead laceration)
- HEMS physician does not escort patient to the hospital (and patient is not dead on the scene after inclusion)
- Workload too high to ensure standard level of clinical care during the study
- Known special vulnerability including known mental disability (permanent, not related to acute condition), patients in nursing homes, prisoners and forensic psychiatric patients.
- Known or evident pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disturbance-free time of the total monitoring time Prehospital phase Proportion of time with readable monitor signal of the total time monitor connected to the patient
Cerebral desaturation events During prehospital phase after induction of anesthesia Number of patients with forehead regional oxygen saturation ≤50% for ≥5 minutes
- Secondary Outcome Measures
Name Time Method On-scene time Prehospital phase Time from arrival of helicopter emergency medical services unit on the patient to beginning of transportation
Neurologic disability 30 days, 12 months 3-6 on modified Rankin scale (range from 0 \[no symptoms at all\] to 6 \[dead\], evaluated by trained research nurse
Health related quality of life 12 months total score of 15-D questionnaire including 15 dimensions each ranked from 1 (good quality of life) to 5 (poor quality of life)
Qualitative feedback from HEMS crews Prehospital phase Comments on the usability of the study device
Survival 30 days, 12 months Data from population registry center
Trial Locations
- Locations (2)
FinnHEMS 50 / Oulu University Hospital
🇫🇮Oulu, Finland
FinnHEMS 10 / Helsinki Univeristy Hospital
🇫🇮Vantaa, Finland